Moneycontrol
HomeNewsBusinessAnnouncementsZydus' Nesher Pharmaceuticals receives final approval for Oseltamivir Phosphate capsules
Trending Topics
Sensex Live
Ceigall India Shares
Pace Digitek IPO GMP
Anand Rathi Share and Stock Brokers IPO

Zydus' Nesher Pharmaceuticals receives final approval for Oseltamivir Phosphate capsules

Nesher Pharmaceuticals, a subsidiary of Zydus Pharmaceuticals USA has received final approval from the USFDA to market Oseltamivir Phosphate Capsules, USP in strengths of 30mg, 45mg, and 75mg.

February 27, 2017 / 12:36 IST
Story continues below Advertisement
Remove Ad

Cadila Healthcare Ltd has informed BSE regarding a Press Release dated February 27, 2017 titled "Zydus' Nesher Pharmaceuticals receives final approval from the USFDA for Oseltamivir Phosphate Capsules".Source : BSE

Read all announcements in Cadila Health

Read More

first published: Feb 27, 2017 12:36 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Follow Us On: Facebook twitter instagram linkedin telegram youtube
Trending Topics
Sensex Today Pharma Stocks Trump Tariffs on Pharma Vodafone Idea News MiG 21 Retirement GST Rate Cut Inderjeet Singh Gosal Mukhyamantri Mahila Rojgar Yojana Tax Audit Extension BTC Election Results
News
Business Markets Stocks India News City News Economy Mutual Funds Personal Finance IPO News Startups
Markets
Home Currencies Commodities Pre-Market IPO Global Market Bonds
Personal Finance
Home Loans up to 50 Lakhs Credit Cards Lifetime Free Finance Tracker New Fixed Deposits Fixed Deposit Comparison Fixed Income
Mutual Funds
Home MC 30 Top Ranked Funds ETFs Mutual Fund Screener
Tools
Income Tax Calculator EMI Calculator Retirement Planning Gratuity Calculator Petrol Price in India Diesel Price in India IFSC Code
Community
Stock Markets
Network 18 Sites
News18 Firstpost CNBC TV18 News18 Hindi Cricketnext Overdrive
Quick Links
About Us Contact Us Advisory Alert Advertise with Us Disclaimer Privacy Policy Cookie Policy Terms & Conditions Financial Terms (Glossary) Sitemap Investors
Download MC Apps:

Copyright © Network18 Media & Investments Limited. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.